NYSE:APUS | Income Statement | Apimeds Pharmaceuticals US, Inc.

Complete source-backed income-statement history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$959,742.00$6.28M-$6.28M-$13.89M-$20.17M-$11.77-$11.771,713,4021,713,402
2026-03-31$901,144.00$12.19M-$12.19M-$22.87M-$35.06M-$2.26-$2.2615,513,38915,513,389
2025-12-31$361,104.00$7.04M-$7.04M$5.88M-$1.16M-$0.08-$0.08572,996572,996
2025-09-30$619,693.00$1.84M-$1.84M$62,984.00-$1.78M-$0.14-$0.1412,575,98312,575,983
2025-06-30$651,784.00$2.66M-$2.66M$1,711.00-$2.66M-$2.57-$2.571,036,9131,036,913
2025-03-31$364,368.00-$364,368.00-$38,029.00-$402,397.00-$0.05-$0.057,903,8507,903,850
2024-12-31$275,613.00-$275,613.00-$36,020.00-$311,633.00-$0.04-$0.0400
2024-09-30$299,999.00-$299,999.00-$32,522.00-$332,521.00-$0.04-$0.047,903,8507,903,850
2024-06-30$427,757.00-$427,757.00-$21,606.00-$449,363.00-$0.06-$0.067,903,8507,903,850
2024-03-31-$271,726.00-$24,747.00-$296,473.00-$0.04-$0.047,903,8507,903,850

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.63M$11.91M-$11.91M$5.91M-$6M-$0.55-$0.5510,881,90710,881,907
2024-12-31$1.28M-$1.28M-$114,895.00-$1.39M-$0.18-$0.187,903,8507,903,850
2023-12-31$98,544.00-$747,436.00-$30,258.00-$777,694.00-$0.17-$0.174,598,265